{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:26Z","timestamp":1790674106882,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233049","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:36:18Z","timestamp":1590154578000},"page":"e0233049","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of CD4\/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-1461","authenticated-orcid":true,"given":"Dawit","family":"Wolday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazezew","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsisa","family":"Legesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawd S.","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-8032","authenticated-orcid":true,"given":"Joseph A.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0454-895X","authenticated-orcid":true,"given":"Robert","family":"Striker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"pone.0233049.ref001","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"M Badri","year":"2002","journal-title":"Lancet"},{"key":"pone.0233049.ref002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"GL Dean","year":"2002","journal-title":"AIDS"},{"key":"pone.0233049.ref003","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"E Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"pone.0233049.ref004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"C Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0233049.ref005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: Long term incidence and risk factors in a South African cohort","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"key":"pone.0233049.ref006","doi-asserted-by":"crossref","first-page":"e34156","DOI":"10.1371\/journal.pone.0034156","article-title":"Tuberculosis incidence rates during 8 years follow-up of an antiretroviral treatment cohort in South Africa: Comparison with rates in the community","volume":"7","author":"A Gupta","year":"2012","journal-title":"LoS ONE"},{"key":"pone.0233049.ref007","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"SD Lawn","year":"2009","journal-title":"AIDS"},{"key":"pone.0233049.ref008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"D Moore","year":"2007","journal-title":"AIDS"},{"key":"pone.0233049.ref009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","article-title":"Tuberculosis in patients receiving antiretroviral therapy: incidence, risk factors and prevention strategies","volume":"56","author":"A van Rie","year":"2011","journal-title":"J Acquir Defic Syndr"},{"key":"pone.0233049.ref010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cis203","article-title":"Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries","volume":"54","author":"J del Amo","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pone.0233049.ref011","first-page":"318","article-title":"Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso","volume":"14","author":"M Demb\u00e9l\u00e9","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0233049.ref012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e318218a713","article-title":"Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs","volume":"57","author":"S Nicholas","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0233049.ref013","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","article-title":"Tuberculosis incidence rate and risk factors among HIV\u2014infected adults with access to antiretroviral therapy","volume":"29","author":"E Liu","year":"2015","journal-title":"AIDS"},{"key":"pone.0233049.ref014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-6405-3-10","article-title":"Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients","volume":"3","author":"D Jerene","year":"2006","journal-title":"AIDS Research Therapy"},{"key":"pone.0233049.ref015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","article-title":"Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV\/ AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study","volume":"17","author":"M Semu","year":"2017","journal-title":"BMC Infectious Diseases"},{"key":"pone.0233049.ref016","doi-asserted-by":"crossref","first-page":"e016961","DOI":"10.1136\/bmjopen-2017-016961","article-title":"Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-East Ethiopia: a retrospective cohort study","volume":"8","author":"A Ahmed","year":"2018","journal-title":"BMJ Open"},{"key":"pone.0233049.ref017","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12879-019-4361-0","article-title":"Incidence of tuberculosis among HIV infected individuals on long-term antiretroviral therapy in private healthcare sector in Pune, Western India","volume":"19","author":"A Dravid","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"pone.0233049.ref018","first-page":"10093","article-title":"A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patients","volume":"9","author":"NS Wong","year":"2019","journal-title":"Sci Reports"},{"key":"pone.0233049.ref019","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"SD Lawn","year":"2006","journal-title":"AIDS"},{"key":"pone.0233049.ref020","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: A systematic review and meta-analysis","volume":"9","author":"AB Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"pone.0233049.ref021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/QAI.0000000000000060","article-title":"High rates of tuberculosis in patients accessing HAART in rural South Africa","volume":"65","author":"K Naidoo","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0233049.ref022","unstructured":"World Health Organization. Global Tuberculosis Report, 2018."},{"key":"pone.0233049.ref023","doi-asserted-by":"crossref","first-page":"20052","DOI":"10.7448\/IAS.18.1.20052","article-title":"CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients","volume":"18","author":"W Lu","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"pone.0233049.ref024","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-200009080-00007","article-title":"Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection","volume":"14","author":"M Plana","year":"2000","journal-title":"AIDS"},{"key":"pone.0233049.ref025","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/infdis\/jiu669","article-title":"Course and clinical significance of CD8 counts in a large HIV cohort","volume":"211","author":"M Helleberg","year":"2015","journal-title":"J Infect Dis"},{"key":"pone.0233049.ref026","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.1302596","article-title":"Multiparametric bioinformatics distinguish the CD4\/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection","volume":"192","author":"M Buggert","year":"2014","journal-title":"J Immunol"},{"key":"pone.0233049.ref027","first-page":"110","article-title":"Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians","volume":"7","author":"D Wolday","year":"2003","journal-title":"Intern J Tubercle Lung Dis"},{"key":"pone.0233049.ref028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","article-title":"The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression","volume":"66","author":"S Serrano-Villar","year":"2013","journal-title":"J Infect"},{"key":"pone.0233049.ref029","unstructured":"Federal Ministry of Health (MoH). HIV\/AIDS Prevention and Control Office. National Guidelines for Use of Antiretroviral Drugs in Ethiopia. MoH, Addis Ababa, Ethiopia, 2001."},{"key":"pone.0233049.ref030","unstructured":"Federal Ministry of Health. National Tuberculosis and Leprosy Control Program Manual, MoH, Addis Ababa, Ethiopia, 2002."},{"key":"pone.0233049.ref031","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/CDLI.6.3.410-414.1999","article-title":"Immunohematological reference ranges for adult Ethiopians","volume":"6","author":"A Tsegaye","year":"1999","journal-title":"Clin Diag Lab Immunol"},{"key":"pone.0233049.ref032","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/CDLI.8.6.1171-1176.2001","article-title":"Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales","volume":"8","author":"A Kassu","year":"2001","journal-title":"Clin Diag Lab Immunol"},{"key":"pone.0233049.ref033","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","article-title":"CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study","volume":"2","author":"C Mussini","year":"2015","journal-title":"Lancet"},{"key":"pone.0233049.ref034","doi-asserted-by":"crossref","first-page":"e97011","DOI":"10.1371\/journal.pone.0097011","article-title":"Clinical, immunological and treatment-related factors associated with normalized CD4+\/CD8+ T-cell ratio: effect of naive and memory T-cell subsets","volume":"9","author":"W Tinago","year":"2014","journal-title":"PLoS One"},{"key":"pone.0233049.ref035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12879-019-4031-2","article-title":"The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis","volume":"19","author":"D Geremew","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"pone.0233049.ref036","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5588\/ijtld.11.0402","article-title":"Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV infected Thai patients","volume":"16","author":"T Khawcharoenporn","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0233049.ref037","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12879-019-3696-x","article-title":"Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study","volume":"19","author":"A Sabasaba","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0233049.ref038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0000000000001560","article-title":"Incidence of tuberculosis among HIV-positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa","volume":"77","author":"P Bock","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0233049.ref039","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","article-title":"How effectively does HAART restore immune responses to mycobacterium tuberculosis? Implications for tuberculosis control","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"key":"pone.0233049.ref040","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.7448\/IAS.20.1.21327","article-title":"HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies","volume":"20","author":"L Fenner","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"pone.0233049.ref041","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.5588\/ijtld.13.0757","article-title":"Development of tuberculosis in HIV-infected patients receiving antiretroviral therapy","volume":"18","author":"E Martin-Echevarria","year":"2014","journal-title":"Int J Tubercle Lung Dis"},{"key":"pone.0233049.ref042","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-6405-10-18","article-title":"Virological and immunological outcome of HAART in HIV-infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia","volume":"10","author":"D Kassa","year":"2013","journal-title":"AIDS Res Therapy"},{"key":"pone.0233049.ref043","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jinf.2013.11.016","article-title":"Incomplete restoration of Mycobacterium tuberculosis-specific CD4 T-cell responses despite antiretroviral therapy","volume":"68","author":"DC Hsu","year":"2014","journal-title":"J Infect"},{"key":"pone.0233049.ref044","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12879-017-2627-y","article-title":"Immunological recovery in tuberculosis\/HIV co-infected patients on antiretroviral therapy: implications for tuberculosis preventive therapy","volume":"17","author":"B Karo","year":"2017","journal-title":"BMC Infect Dis"},{"key":"pone.0233049.ref045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/jinf.2000.0721","article-title":"Tuberculosis associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar, SIDAK Research Group","volume":"41","author":"SJ Kony","year":"2000","journal-title":"J Infect"},{"key":"pone.0233049.ref046","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2334-12-66","article-title":"CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection","volume":"12","author":"AB Andersen","year":"2012","journal-title":"BMC Infect Dis"},{"key":"pone.0233049.ref047","doi-asserted-by":"crossref","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","article-title":"Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in Sub-Saharan Africa","volume":"5","author":"SM Hermans","year":"2010","journal-title":"PLoS ONE"},{"key":"pone.0233049.ref048","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2249.2003.02106.x","article-title":"Role of incident and\/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-infected and uninfected adult Ethiopians","volume":"132","author":"A Kassu","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"pone.0233049.ref049","doi-asserted-by":"crossref","first-page":"e0192030","DOI":"10.1371\/journal.pone.0192030","article-title":"Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana","volume":"13","author":"L Mupfumi","year":"2018","journal-title":"PLoS ONE"},{"key":"pone.0233049.ref050","doi-asserted-by":"crossref","first-page":"e0211688","DOI":"10.1371\/journal.pone.0211688","article-title":"Breakthrough tuberculosis among people with HIV\u2014Should we be worried? A retrospective longitudinal study","volume":"14","author":"KD Yirdaw","year":"2019","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:36:52Z","timestamp":1590154612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233049"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233049","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}